Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/18/2004 | CN1476483A Modified vaccinia ankara virus variant |
02/18/2004 | CN1476479A Human protooncogene and protein encoded therein |
02/18/2004 | CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein |
02/18/2004 | CN1476477A Promoter expressing foreign gene in root and shoot apex |
02/18/2004 | CN1475577A Recombination human bone shaping protein-7 mature peptide |
02/18/2004 | CN1475575A Process for obtaining amino-acid ingredient by zymohydrolysis of roe skin |
02/18/2004 | CN1475503A New type human bone marrow substrate cell source growth inhibiting factor, its coded sequence and use |
02/18/2004 | CN1475502A New withered induced protein, its coded sequence and use |
02/18/2004 | CN1475501A New type human bone marrow substrate cell source 1 type phosphoric acid enzyme inhibition factor, its coded sequence and use |
02/18/2004 | CN1475500A New type human marrow differentiation tagged object its coded sequence and use |
02/18/2004 | CN1475499A New type human cell signal related protein, its code sequence and use |
02/18/2004 | CN1138856C Engineering bacteria for epidermal growth factor and preparation of epidermal growth factor by using this bacteria |
02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
02/18/2004 | CN1138564C Influenza vaccine |
02/17/2004 | US6693181 Protein secretion |
02/17/2004 | US6693175 Detecting and treating bone disorder of humans |
02/17/2004 | US6693174 Nucleotide sequences coding fungicide for use in the prevention of fungal infections |
02/17/2004 | US6693081 Bone stimulating factor |
02/17/2004 | US6693075 Factor viia polypeptide comprising modified carboxyglutamic acid domain; enhancing membrane binding affinity and activity |
02/17/2004 | US6692948 Isolated human kinase proteins |
02/17/2004 | US6692943 Persephin and related growth factors |
02/17/2004 | US6692942 Single-chain polypeptides for targeted delivery of nucleic acids |
02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
02/17/2004 | US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides |
02/17/2004 | US6692932 Thermostable DNA polymerase from anaerocellum thermophilum |
02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
02/17/2004 | US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 |
02/17/2004 | US6692742 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
02/17/2004 | US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence |
02/17/2004 | US6691457 Floral packaging material having great masters prints thereon |
02/17/2004 | CA2143325C Cloning and expression of .beta.app-c100 receptor |
02/17/2004 | CA2112667C Monoclonal antibodies to putative hcv ns5 proteins and methods for using same |
02/12/2004 | WO2004013326A1 Cartilage differentiation inhibiting gene |
02/12/2004 | WO2004013303A2 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
02/12/2004 | WO2004013175A1 SYNTHETIC GENE CODING FOR HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR FOR THE EXPRESSION IN E. coli |
02/12/2004 | WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
02/12/2004 | WO2004012756A1 New cytotoxic cyclopeptide and its use for the treatment of cancer |
02/12/2004 | WO2004012681A2 Cancer vaccines containing epitopes of oncofetal antigen |
02/12/2004 | WO2004012658A2 Method and device for protein delivery into cells |
02/12/2004 | WO2003102152A3 Methods and materials for the production of lactic acid in yeast |
02/12/2004 | WO2003097812A3 Transgenic ungulates capable of human antibody production |
02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
02/12/2004 | WO2003089617A3 Methods for increasing homologous recombination of a nucleic acid sequence |
02/12/2004 | WO2003089454A3 Unnatural amino acid containing display libraries |
02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
02/12/2004 | WO2003080802A3 Nucleic acid constructs and methods for producing altered seed oil compositions |
02/12/2004 | WO2003072037A3 High-level production of amyloid-beta peptides from imr-32 cells |
02/12/2004 | WO2003072014A3 Minicell compositions and methods |
02/12/2004 | WO2003068923A9 Signal for packaging of influenza virus vectors |
02/12/2004 | WO2003033653B1 Affinity enhancement agents |
02/12/2004 | WO2003022225A3 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
02/12/2004 | WO2003015710A3 Combined drug and csf removal therapies and systems |
02/12/2004 | WO2003010282A3 Interleukin-1 beta antibodies |
02/12/2004 | WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules |
02/12/2004 | WO2002086089A3 The 76a11 polypeptide and uses thereof |
02/12/2004 | WO2002081507A3 Interferon gamma polypeptide variants |
02/12/2004 | WO2002080848A3 Methods and materials for cancer treatment |
02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
02/12/2004 | WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution |
02/12/2004 | WO2002046411A3 Intestinal proteins |
02/12/2004 | WO2002040686A3 Expression system for recombinant proteins |
02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
02/12/2004 | US20040029278 Recombinant alphaviruses which are capable of expressing a heterologous sequence in target cells |
02/12/2004 | US20040029256 Genetically modified Kluyveromyces cells, methods for making them, and their use in production of organic products, particularly D-lactic acid |
02/12/2004 | US20040029252 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
02/12/2004 | US20040029232 Novel G-protein coupled receptors |
02/12/2004 | US20040029229 High level protein expression system |
02/12/2004 | US20040029228 Cytokine receptor |
02/12/2004 | US20040029225 Lipoxygenase |
02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
02/12/2004 | US20040029174 End selection in directed evolution |
02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
02/12/2004 | US20040028701 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
02/12/2004 | CA2493745A1 Method and device for protein delivery into cells |
02/11/2004 | EP1388733A1 METHOD OF SCREENING GERM FOR CELL−FREE PROTEIN SYNTHESIS AND METHOD OF PRODUCING GERM EXTRACT FOR CELL−FREE PROTEIN SYNTHESIS |
02/11/2004 | EP1387889A2 Kinases and phosphatases |
02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
02/11/2004 | EP1387886A2 Proteases |
02/11/2004 | EP1387884A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |